← Eichor
Condition: Esophageal Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Esophageal Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
NA · 1 location(s) · Fudan University · NCT07272382An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
Phase 3 · 1 location(s) · Ruijin Hospital · NCT06339060Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821843Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07177794A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · 62 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combin
Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT06232083Exercise Prehabilitation for Locoregional Esophageal Cancer
NA · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06430346Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurg
Phase 1 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07317609Chemoradiotherapy in Unresectable Esophageal Cancer
Phase 1/Phase 2 · 5 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04278287DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07162506Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophag
Phase 3 · 1 location(s) · Renmin Hospital of Wuhan University · NCT05919030AB122 Platform Study
Phase 1 · 9 location(s) · Taiho Pharmaceutical Co., Ltd. · NCT04999761Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
Phase N/A · 6 location(s) · Sun Yat-sen University · NCT07309991Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NA · 1 location(s) · Anhui Provincial Hospital · NCT06602843MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT02988921Novel Treatment of Radiation Associated Dysphagia With Statins
Phase 2 · 1 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07217938Total Intravenous Anesthesia and Recurrence Free Survival
Phase 3 · 1 location(s) · The Cleveland Clinic · NCT04513808MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma
Phase 1 · 1 location(s) · UMC Utrecht · NCT07359417Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07043491Balloon Dilation in Patients Undergoing Minimally Invasive Ivor Lewis Esophagectomy and Its Effect on Reducing DGCE
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07355374A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06769113Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
NA · 23 location(s) · University of Colorado, Denver · NCT05753748High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
NA · 3 location(s) · Zhejiang University · NCT07307560TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05188313Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · 97 location(s) · AstraZeneca · NCT06535607A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or
Phase 1/Phase 2 · 1 location(s) · AP Biosciences Inc. · NCT05473156Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT04138212A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Phase 1 · 31 location(s) · Eli Lilly and Company · NCT07114601
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.